Caring for Our Own seminar included panels on Alzheimer's and other forms of dementia, as well as tips on preparing for ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

The National Institutes of Health, the primary source of federal funding for medical research in the U.S., announced Feb. 7 ...

A recent study reveals that daily caffeine consumption may result in reduced gray matter volume in the brain. Despite this, ...

Genes play a role in whether someone gets Alzheimer's, but new research from Northeastern University psychology and ...

Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

It’s more than a financial blow; it’s a betrayal of the families who are depending on breakthroughs in cancer treatment, Alzheimer’s research, and other critical health challenges.” ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

The community is invited to learn about their brain health during a free month-long webinar series every Thursday to spread ...